HEOR Evidence Generation.
Demonstrate the value of your therapies.
What we do.
Demonstrate value through proven analytical methods and lead the discussion for valuing new innovations.
Our team of health economists and HEOR strategists apply deep HTA experience to inform your reimbursement strategy, guide you through HTA processes, and support your value communications strategies beyond product launch.
How we help.
Leverage proven analytical methods for HEOR evidence generation with our commercial experience and scientific expertise. Our economic modelling and HTA specialists can inform pricing strategy, identify priorities for evidence generation, and develop global models that meet the latest HTA requirements, including for local submissions.
Beyond that, we maintain a team of highly qualified Patient Reported Outcomes (PRO) specialists who generate and analyze health-related utility data to strengthen your product’s value proposition.
Our HEOR strategies include:
- Early economic and budget impact models
- Patient-Reported Outcome (PRO) solutions
- Burden of illness and patient preference studies
- Evidence generation strategies for HTA submissions
Featured case study
HTA evidence generation & preparedness for a novel oncology treatment.
Latest thinking.
Get the latest insights and perspectives from our experts.
-
Read more
HTA evidence generation and preparedness for a novel oncology treatment
Our client needed successful HTA evidence packages and submissions to achieve reimbursement across Europe for an innovative oncology treatment.
-
Read more
Webinar on the IRA in partnership with BioCentury
Scott Briggs, Principal, joined a live panel of industry experts to discuss the Inflation Reduction Act on March 30th.
-
Read more
Indirect treatment comparison (ITC) to generate comparative effectiveness evidence
A company was approaching the European market with evidence from a placebo-controlled RCT, but with several established competitors.
-
Read more
Early value insights to drive value definition and evidence need to produce TrPP
The client wanted to understand the key drivers of value for the new treatment for sleep disorders including narcolepsy.
Get in touch.
Looking to get in touch with an expert or team member?
Tell us how we can help.
Related offerings.
-
Value, Pricing & Access
-
Evidence Synthesis & RWE Generation
-
Value, Pricing & Access Strategy